Increased CD163 + infiltration is associated in most studies with dismal prognosis in breast cancer patients [20, 21], although there is no consistency on the prognostic impact of CD163 + density among different breast cancer subtypes [22]. The gene discussed is CD163; the disease is breast carcinoma.